NCT07312526Completed
Shanghai Clinical Cohort - Esophageal Cancer
Shanghai Clinical Cohort - Esophageal Cancer Cohort
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2116 (actual)
- First submitted
- 17 Nov 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Shanghai Chest Hospital
- NCT number
- NCT07312526
What you commit to
- Study type: Observational
- Participants enrolled: 2116
- From 1 Jul 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- No esophagectomy.
Who the study is looking for
- Received esophagectomy in these centers for esophageal cancer.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shanghai Chest Hospital Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.